View |
|
DRP-15483-04
|
Dapagliflozin (as propanediol monohydrate)
|
None
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose transporter 2(SGLT2) Inhibitor]
|
Stallion Laboratories Pvt.Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
16 July 2029
|
View |
|
DRP-15483-01
|
Dapagliflozin (as propanediol monohydrate)
|
SciGliFlo
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
|
Stallion Laboratories Pvt.Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
16 July 2029
|
View |
|
DRP-15585-01
|
Nystatin
|
Gozenyst
|
100,000 IU/mL
|
Oral Suspension
|
Antifungal
|
S Kant Healthcare Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
06 August 2029
|
View |
|
DRP-15663-01
|
Losartan Potassium
|
Raptrasol
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
28 September 2024
|
16 August 2029
|
View |
|
DRP-15500-01
|
Atorvastatin (as calcium trihydrate)
|
Stadin
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
CLIDP Conversion
|
29 September 2024
|
29 July 2029
|
View |
|
DRP-15585-02
|
Nystatin
|
Retanyst
|
100,000 IU/mL
|
Oral Suspension
|
Antifungal
|
S Kant Healthcare Ltd.
|
India
|
CLIDP Conversion
|
23 September 2024
|
06 August 2029
|
View |
|
DRP-15451-01
|
Clopidogrel (as bisulfate)
|
Plavicar
|
75 mg
|
Film Coated Tablet
|
Antithrombotic Agent
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
27 September 2024
|
11 July 2029
|
View |
|
DRP-15501-01
|
Atorvastatin (as calcium trihydrate)
|
Stadin
|
10 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
CLIDP Conversion
|
29 September 2024
|
29 July 2029
|
View |
|
DRP-15663-02
|
Losartan Potassium
|
Losartap
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
28 September 2024
|
16 August 2029
|